Research Area: Neurological Disease Biological Activity: Sumatriptan succinate(mitrex, Imigran) is a triptan sulfa drug containing a sulfonamide group for the treatment of migraine headaches. Sumatriptan is structurally similar to serotonin (5HT), and is a 5-HT (types 5-HT1D and 5-HT1B) agonist. The specific receptor subtypes it activates are present on the cranial arteries and veins. Acting as an agonist at these receptors, Sumatriptan reduces the vascular inflammation associated with migraine. [1]
A succinate salt obtained by reaction of sumatriptan with one equivalent of succinic acid. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used for the acute treatment of migraine with or without aura in adults.
References
PubChem Literature
From Data Sources
• http://www.rxlist.com/imitrex-drug.htm
• Humphrey, P.P.A., et al.: Brit. J. Pharmacol., 94, 1123 (1988)